Carvedilol
82 interactions 5 explained in plain EnglishCarvedilol is a beta-blocker used to treat heart failure, high blood pressure, and recovery after a heart attack. Read the full Carvedilol drug information page →
Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →
Contraindicated
Carvedilol Colchicine Colcrys Explained Increased colchicine exposure and an increased risk of colchicine toxicity DetailsMajor
Carvedilol Sertraline Explained Increased CYP2D6 substrate exposure Details Carvedilol Albuterol Oral Inhalation Accuneb® Explained Reduced efficacy of albuterol Details Carvedilol Relugolix Orgovyx Explained Increased relugolix exposure Details Carvedilol Betrixaban Bevyxxa® Increased betrixaban exposure and increased risk of bleeding Details Carvedilol Abiraterone Abirtega Increased CYP2D6 substrate exposure and an increased risk of CYP2D6 substrate-related adverse effects Details Carvedilol Afatinib Gilotrif Increased exposure of afatinib Details Carvedilol Capecitabine Xeloda Increased exposure of CYP2C9 substrates and an increased risk of CYP2C9 substrates-related adverse effects Details Carvedilol Clonidine Transdermal Patch Catapres An increased risk of worsen sinus node dysfunction and atrioventricular node conduction, an increased risk of bradycardia and AV b... Details Carvedilol Dabigatran Pradaxa® Increased dabigatran exposure and an increased risk of bleeding Details Carvedilol Dabigatran Etexilate Increased dabigatran exposure and an increased risk of bleeding Details Carvedilol Digoxin Cardoxin® Increased digoxin exposure and an increased risk of bradycardia and advanced or complete heart block Details Carvedilol Doxorubicin Adriamycin Increased DOXOrubicin exposure and an increased risk of DOXOrubicin-related adverse reactions Details Carvedilol Fluorouracil Adrucil Increased exposure of CYP2C9 substrates and an increased risk of CYP2C9 substrates-related adverse effects Details Carvedilol Fluorouracil Injection Adrucil Increased exposure of CYP2C9 substrates and an increased risk of CYP2C9 substrates-related adverse effects Details Carvedilol Fluorouracil Topical Carac Increased exposure of CYP2C9 substrates and an increased risk of CYP2C9 substrates-related adverse effects Details Carvedilol Indacaterol Oral Inhalation Arcapta® Decreased efficacy of indacaterol Details Carvedilol Lacosamide Injection Motpoly An increased risk of AV block, bradycardia, and ventricular tachyarrhythmia Details Carvedilol Lefamulin Xenleta Increased lefamulin exposure and an increased risk of lefamulin-related adverse reactions Details Carvedilol Loperamide Diamode Increased loperamide exposure and an increased risk of loperamide-related adverse effects Details Carvedilol Methylergonovine Methergine An increased risk of enhanced vasoconstrictive Details Carvedilol Miconazole Buccal Oravig Increased carvedilol concentrations and an increased risk of bradycardia or heart block Details Carvedilol Miconazole Topical Aloe Vesta Antifungal Increased carvedilol concentrations and an increased risk of bradycardia or heart block Details Carvedilol Miconazole Vaginal Lagicam Increased carvedilol concentrations and an increased risk of bradycardia or heart block Details Carvedilol Miconazole Aloe Vesta Antifungal Increased carvedilol concentrations and an increased risk of bradycardia or heart block Details Carvedilol Morphine Injection Astramorph® PF Increased morphine exposure and an increased risk of morphine-related adverse effects (hypotension, respiratory depression, profou... Details Carvedilol Olodaterol Oral Inhalation Striverdi Reduced olodaterol exposure and reduced beta-adrenergic blockers exposure DetailsModerate
Carvedilol Acarbose Prandase® Explained Hypoglycemia or hyperglycemia; decreased symptoms of hypoglycemia Details Carvedilol Asenapine Transdermal Patch Secuado An increased risk of hypotension Details Carvedilol Aspirin Acuprin® Reduced antihypertensive effect Details Carvedilol Aspirin Rectal Aspirin Reduced antihypertensive effect Details Carvedilol Alfuzosin UroXatral An exaggerated hypotensive response to the first dose of the alpha blocker Details Carvedilol Alogliptin Nesina Hypoglycemia or hyperglycemia; decreased symptoms of hypoglycemia Details Carvedilol Bromfenac Ophthalmic Bromday® Reduced antihypertensive effect Details Carvedilol Canagliflozin Invokana Hypoglycemia or hyperglycemia; decreased symptoms of hypoglycemia Details Carvedilol Cyclosporine Injection Atopica An increased risk of cycloSPORINE toxicity (renal dysfunction, cholestasis, paresthesias) Details Carvedilol Cyclosporine Ophthalmic Cequa An increased risk of cycloSPORINE toxicity (renal dysfunction, cholestasis, paresthesias) Details Carvedilol Dapagliflozin Farxiga Hypoglycemia or hyperglycemia; decreased symptoms of hypoglycemia Details Carvedilol Diclofenac Ophthalmic Voltaren® Eye Drops Reduced antihypertensive effect Details Carvedilol Diclofenac Topical (Actinic Keratosis) Pennsaid Reduced antihypertensive effect DetailsNo interactions on this page match that filter — try the next page or clear the filter.
Check another drug
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist